Name
TAASTUSRAVI KLIINIK NEUROTRA OSAÜHING
Registry code
10793591
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
17.09.2001 (23)
Financial year
01.01-31.12
Capital
2 682.00 €
Activity
86909 - Other healthcare activities not classified elsewhere
19 134 €
4 740 €
25%
-
8 179 €
1
Submitted
No tax arrears
58%
51%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Eva Paas 16.02.1954 (70) | 33% - 894.00 EUR | Board member | Direct ownership | Founder |
Maret Tammeka 29.11.1951 (72) | 33% - 894.00 EUR | Board member | Direct ownership | Founder |
Ivi Abram 12.06.1956 (68) | 33% - 894.00 EUR | - | Direct ownership |
2019 30.06.2020 | 2020 21.06.2021 | 2021 29.06.2022 | 2022 25.06.2023 | 2023 20.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 37 548 € | 33 442 € | 24 133 € | 32 189 € | 19 134 € |
Net profit (loss) for the period | 15 282 € | 21 110 € | 6 696 € | 14 309 € | 4 740 € |
Profit Margin | 41% | 63% | 28% | 44% | 25% |
Current Assets | 27 281 € | 35 409 € | 17 847 € | 21 379 € | 9 374 € |
Fixed Assets | 75 € | 0 € | 0 € | 0 € | 0 € |
Total Assets | 27 356 € | 35 409 € | 17 847 € | 21 379 € | 9 374 € |
Current Liabilities | 1 347 € | 291 € | 1 032 € | 1 647 € | 1 195 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 26 009 € | 35 118 € | 16 815 € | 19 732 € | 8 179 € |
Employees | 1 | 1 | 1 | 1 | 1 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 459.87 € | 466.64 € | 1 |
2023 Q4 | - | 795 € | 807 € | 1 |
2023 Q3 | - | 4 519.65 € | 1 927 € | 1 |
2023 Q2 | - | 795 € | 807 € | 1 |
2023 Q1 | - | 795 € | 807 € | 1 |
2022 Q4 | - | 795 € | 807 € | 1 |
2022 Q3 | - | 3 588.49 € | 1 647 € | 1 |
2022 Q2 | - | 795 € | 807 € | 1 |
2022 Q1 | - | 795 € | 807 € | 1 |
2021 Q4 | - | 795 € | 807 € | 1 |
2021 Q3 | - | 6 895.85 € | 1 413.67 € | 1 |
2021 Q2 | - | 1 060 € | 1 076 € | 1 |
2021 Q1 | - | - | - | 1 |
2020 Q4 | - | 2 920.44 € | 326.67 € | 1 |
2020 Q3 | - | - | - | 1 |
2020 Q2 | - | 319 € | 322.8 € | 1 |
2020 Q1 | - | 955.41 € | 968.4 € | 1 |